METS-IR与心血管疾病研究进展

doi:10.3760/cma.j.issn.1007-1245.2024.14.001

摘要/Abstract

摘要：

随着生活水平提高，心血管疾病发病率及病死率逐年上升，已成为重要的公共卫生问题。胰岛素抵抗状态与心血管疾病发生及发展中的病理生理过程密切相关。深入研究二者之间的内在联系对于心血管疾病的早期预防、治疗和随访至关重要。传统的胰岛素抵抗检测方法操作繁琐、耗时，价格昂贵，不适合在医院开展，更无法在大规模人群中推广。胰岛素抵抗代谢评分（METS-IR）是一个新型的胰岛素抵抗预测指标，其反映胰岛素抵抗具有高效及简便的特点，并且METS-IR升高与心血管疾病发生及不良心血管预后具有正相关性。基于此，本文就METS-IR对常见心血管疾病的诊断及临床应用价值进行综述。

关键词:

心血管疾病, 胰岛素抵抗代谢评分, 胰岛素抵抗, 进展

Abstract:

With the improvement of living standards, the incidence and mortality of cardiovascular diseases are increasing year by year and have become an important public health problem. Insulin resistance status is closely related to the pathophysiologic process in the occurrence and development of cardiovascular diseases. In-depth study of the intrinsic link between insulin resistance and cardiovascular diseases is essential for early prevention, treatment, and follow-up of cardiovascular diseases. Traditional insulin resistance testing methods are cumbersome, time-consuming, and expensive, making them unsuitable for hospitals, not to mention being unable to be generalized in large-scale populations. Metabolic Score for Insulin Resistance (METS-IR) is a new type of predictors of insulin resistance, and METS-IR reflects insulin resistance with high efficiency and simplicity. Moreover, elevated METS-IR is positively correlated with cardiovascular diseases and poor cardiovascular prognosis. Based on this, this article summarizes the diagnostic and clinical value of METS-IR in common cardiovascular diseases.

Key words:

Cardiovascular diseases, METS-IR, Insulin resistance, Progress

王新宇郭义山刘茜王东.

METS-IR与心血管疾病研究进展 [J]. 国际医药卫生导报, 2024, 30(14): 2289-2293.

Wang Xinyu, Guo Yishan, Liu Qian, Wang Dong.

Advances in METS-IR and cardiovascular diseases [J]. International Medicine and Health Guidance News, 2024, 30(14): 2289-2293.

参考文献

[1] 中国心血管健康与疾病报告编写组.«中国心血管健康与疾病报告2022»概要[J].中国介入心脏病学杂志,2023,31(7):485-508. DOI:10.3969/j.issn.1004-8812.2023. 07.002.
[2] Kosmas CE, Bousvarou MD, Kostara CE, et al. Insulin resistance and cardiovascular disease[J]. J Int Med Res, 2023, 51(3):3000605231164548. DOI: 10.1177/03000605231164548.
[3] Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function[J]. Best Pract Res Clin Endocrinol Metab, 2003, 17(3):305-322. DOI: 10.1016/s1521-690x(03)00042-3.
[4] Borai A, Livingstone C, Ferns GA. The biochemical assessment of insulin resistance[J]. Ann Clin Biochem, 2007, 44(Pt 4):324-342. DOI: 10.1258/000456307780945778.
[5] Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes[J]. Eur J Endocrinol, 2018, 178(5):533-544. DOI: 10.1530/EJE-17-0883.
[6] Wu Z, Cui H, Li W, et al. Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease[J]. Front Cardiovasc Med, 2022, 9:918359. DOI: 10.3389/fcvm.2022.918359.
[7] DeFronzo RA. Pathogenesis of type 2 diabetes mellitus[J]. Med Clin North Am, 2004, 88(4):787-835, ix. DOI: 10.1016/j.mcna.2004.04.013.
[8] Joint Committee for Guideline Revision. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension[J]. J Geriatr Cardiol, 2019, 16(3):182-241. DOI: 10.11909/j.issn.1671-5411.2019.03.014.
[9] Zhao L, Meng X, Zhang QY, et al. A narrative review of prehypertension and the cardiovascular system: effects and potential pathogenic mechanisms[J]. Ann Transl Med, 2021, 9(2):170. DOI: 10.21037/atm-20-5482.
[10] Han KY, Gu J, Wang Z, et al. Association between METS-IR and prehypertension or hypertension among normoglycemia subjects in Japan: a retrospective study[J]. Front Endocrinol (Lausanne), 2022, 13:851338. DOI: 10.3389/fendo.2022.851338.
[11] Zhang X, Yu C, Ye R, et al. Correlation between non-insulin-based insulin resistance indexes and the risk of prehypertension: a cross-sectional study[J]. J Clin Hypertens (Greenwich), 2022, 24(5):573-581. DOI: 10.1111/jch.14449.
[12] Yu ES, Hong K, Chun BC. Incidence and risk factors for progression from prehypertension to hypertension: a 12-year Korean Cohort Study[J]. J Hypertens, 2020, 38(9):1755-1762. DOI: 10.1097/HJH.0000000000002494.
[13] Xu C, Song G, Hu D, et al. Association of METS-IR with incident hypertension in non-overweight adults based on a cohort study in Northeastern China[J]. Eur J Public Health, 2022, 32(6):884-890. DOI: 10.1093/eurpub/ckac140.
[14] Liu XZ, Fan J, Pan SJ. METS-IR, a novel simple insulin resistance indexes, is associated with hypertension in normal-weight Chinese adults[J]. J Clin Hypertens (Greenwich), 2019, 21(8):1075-1081. DOI: 10.1111/jch.13591.
[15] Cai X, Hu J, Zhu Q, et al. Relationship of the metabolic score for insulin resistance and the risk of stroke in patients with hypertension: a cohort study[J]. Front Endocrinol (Lausanne), 2022, 13:1049211. DOI: 10.3389/fendo.2022.1049211.
[16] Cho YR, Ann SH, Won KB, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes[J]. Sci Rep, 2019, 9(1):6129. DOI: 10.1038/s41598-019-42700-1.
[17] An X, Yu D, Zhang R, et al. Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study[J]. Cardiovasc Diabetol, 2012, 11:71. DOI: 10.1186/1475-2840-11-71.
[18] Wu Z, Cui H, Zhang Y, et al. The impact of the metabolic score for insulin resistance on cardiovascular disease: a 10-year follow-up cohort study[J]. J Endocrinol Invest, 2023, 46(3):523-533. DOI: 10.1007/s40618-022- 01925-0.
[19] Mahdavi-Roshan M, Mozafarihashjin M, Shoaibinobarian N, et al. Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case‒control investigation with comparison to traditional biomarkers[J]. Lipids Health Dis, 2022, 21(1):126. DOI: 10.1186/s12944-022-01732-9.
[20] Dwivedi AK, Dubey P, Cistola DP, et al. Association between obesity and cardiovascular outcomes: updated evidence from meta-analysis studies[J]. Curr Cardiol Rep, 2020, 22(4):25. DOI: 10.1007/s11886-020-1273-y.
[21] Low S, Khoo KCJ, Irwan B, et al. The role of triglyceride glucose index in development of type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2018, 143:43-49. DOI: 10.1016/j.diabres.2018.06.006.
[22] Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement[J]. Lancet Diabetes Endocrinol, 2019, 7(9):715-725. DOI: 10.1016/S2213-8587(19)30084-1.
[23] Di Pino A, DeFronzo RA. Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents[J]. Endocr Rev, 2019, 40(6):1447-1467. DOI: 10.1210/er.2018-00141.
[24] DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009[J]. Diabetologia, 2010, 53(7):1270-1287. DOI: 10.1007/s00125-010-1684-1.
[25] Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups[J]. N Engl J Med, 2008, 358(13):1336-1345. DOI: 10.1056/NEJMoa072100.
[26] Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J]. Eur Heart J, 2016, 37(29):2315-2381. DOI: 10.1093/eurheartj/ehw106.
[27] Reaven GM, Knowles JW, Leonard D, et al. Relationship between simple markers of insulin resistance and coronary artery calcification[J]. J Clin Lipidol, 2017, 11(4):1007-1012. DOI: 10.1016/j.jacl.2017.05.013.
[28] Wang J, Huang X, Fu C, et al. Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome[J]. Cardiovasc Diabetol, 2022, 21(1):187. DOI: 10.1186/s12933-022-01615-4.
[29] Wang B, Hua J, Ma L. Triglyceride to high-density lipoprotein ratio can predict coronary artery calcification[J]. Pak J Med Sci, 2022, 38(3Part-I):624-631. DOI: 10.12669/pjms.38.3.5290.
[30] Wang Z, Hui X, Huang X, et al. Relationship between a novel non-insulin-based metabolic score for insulin resistance (METS-IR) and coronary artery calcification[J]. BMC Endocr Disord, 2022, 22(1):274. DOI: 10.1186/s12902-022-01180-7.
[31] Ding L, Gao YH, Li YR, et al. Metabolic score for insulin resistance is correlated to adipokine disorder and inflammatory activity in female knee osteoarthritis patients in a Chinese population[J]. Diabetes Metab Syndr Obes, 2020, 13:2109-2118. DOI: 10.2147/DMSO.S249025.
[32] Ye Z, Xie E, Gao Y, et al. The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults[J]. BMC Endocr Disord, 2022, 22(1):242. DOI: 10.1186/s12902-022- 01157-6.
[33] Lee H, Park HE, Yoon JW, et al. Clinical significance of body fat distribution in coronary artery calcification progression in Korean population[J]. Diabetes Metab J, 2021, 45(6):974. DOI: 10.4093/dmj.2021.0304.